Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Institute of Clinical Pharmacy, Central South University, Changsha, Hunan, China.
J Cell Mol Med. 2018 Mar;22(3):1720-1732. doi: 10.1111/jcmm.13453. Epub 2018 Jan 4.
Many studies have examined the associations between paraoxonase-1 (PON1) genetic polymorphisms (Q192R, rs662 and L55M, rs854560) and the susceptibility to type 2 diabetes mellitus (T2DM) across different ethnic populations. However, the evidence for the associations remains inconclusive. In this study, we performed a meta-analysis to clarify the association of the two PON1 variants with T2DM risk. We carried out a systematic search of PubMed, Embase, CNKI and Wanfang databases for studies published before June 2017. The pooled odds ratios (ORs) for the association and their corresponding 95% confidence intervals (CIs) were calculated by a random- or fixed-effect model. A total of 50 eligible studies, including 34 and 16 studies were identified for the PON1 Q192R (rs662) and L55M (rs854560) polymorphism, respectively. As for the PON1 Q192R polymorphism, the 192R allele was a susceptible factor of T2DM in the South or East Asian population (OR > 1, P < 0.05) but represented a protective factor of T2DM in European population (OR = 0.66, 95% CI = 0.45-0.98) under a heterozygous genetic model. With regard to the PON1 L55M polymorphism, significant protective effects of the 55M allele on T2DM under the heterozygous (OR = 0.77, 95% CI = 0.61-0.97) and dominant (OR = 0.80, 95% CI = 0.65-0.99) genetic models were found in the European population, while no significant associations in the Asian populations under all genetic models (P > 0.05). In summary, by a comprehensive meta-analysis, our results firmly indicated that distinct effects of PON1 genetic polymorphisms existed in the risk of T2DM across different ethnic backgrounds.
许多研究已经检验了paraoxonase-1(PON1)基因多态性(Q192R、rs662 和 L55M、rs854560)与 2 型糖尿病(T2DM)易感性之间的关联,这些研究涉及不同的种族群体。然而,关联的证据仍然没有定论。在这项研究中,我们进行了荟萃分析以阐明两种 PON1 变体与 T2DM 风险的关联。我们对截止到 2017 年 6 月发表的研究进行了系统的 PubMed、Embase、CNKI 和万方数据库检索。通过随机或固定效应模型计算关联的汇总优势比(OR)及其相应的 95%置信区间(CI)。共纳入 50 项符合条件的研究,分别有 34 项和 16 项研究针对 PON1 Q192R(rs662)和 L55M(rs854560)多态性。对于 PON1 Q192R 多态性,192R 等位基因是南亚或东亚人群 T2DM 的易感因素(OR > 1,P < 0.05),但在欧洲人群中,杂合遗传模型下 192R 等位基因是 T2DM 的保护因素(OR = 0.66,95%CI = 0.45-0.98)。对于 PON1 L55M 多态性,在欧洲人群中,杂合遗传模型下 55M 等位基因对 T2DM 具有显著的保护作用(OR = 0.77,95%CI = 0.61-0.97),显性遗传模型下也具有保护作用(OR = 0.80,95%CI = 0.65-0.99),而在亚洲人群中,所有遗传模型下均无显著关联(P > 0.05)。总之,通过综合荟萃分析,我们的结果明确表明,PON1 遗传多态性在不同种族背景下对 T2DM 风险的影响存在明显差异。